Quarry LP lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 54.0% in the 1st quarter, HoldingsChannel reports. The firm owned 3,199 shares of the company’s stock after selling 3,757 shares during the quarter. Quarry LP’s holdings in GE HealthCare Technologies were worth $258,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Breakwater Capital Group bought a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at about $210,000. Bessemer Group Inc. raised its holdings in shares of GE HealthCare Technologies by 24.3% in the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock valued at $538,000 after purchasing an additional 1,306 shares in the last quarter. Flagship Harbor Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 17.4% in the 1st quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company’s stock valued at $278,000 after purchasing an additional 511 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of GE HealthCare Technologies by 23.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company’s stock valued at $4,105,000 after purchasing an additional 9,769 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 52.7% in the 1st quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company’s stock valued at $357,000 after purchasing an additional 1,550 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently commented on GEHC. Zacks Research upgraded shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their price objective for the stock from $74.00 to $73.00 in a research report on Monday, May 5th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.55.
GE HealthCare Technologies Stock Up 0.0%
GEHC stock opened at $73.73 on Monday. The firm has a 50 day moving average of $74.23 and a 200 day moving average of $74.55. The stock has a market capitalization of $33.66 billion, a PE ratio of 15.11, a price-to-earnings-growth ratio of 2.82 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period last year, the business earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were paid a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- Breakout Stocks: What They Are and How to Identify Them
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Tencent Music Stock Outshines Spotify as China’s Music Giant
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.